MedDataX Logo

Abu Dhabi Sleep Apnea (ADSA) Study

NCT ID: NCT02403141

Last Updated: 2017-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight \[1\]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance \[2\]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity \[3\]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Obstructive Sleep Apnoea in Patients With Type 1 Diabetes

NCT03481361

Type 1 Diabetes Obstructive Sleep Apnoea
COMPLETED

Predictors of OSA in Patients With COPD

NCT05605431

OSA COPD
COMPLETED

Obstructive Sleep Apnea Prevalence in Patients With Chronic Obstructive Pulmonary Diseases

NCT04903639

OSA
COMPLETED

Prevalence of Sleep Apnea Syndrome in Patients With Type 1 Diabetes

NCT03506022

Diabetes Mellitus, Type 1
COMPLETED NA

Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD

NCT00031239

Sleep Apnea Syndromes Diabetes Mellitus, Non-insulin Dependent Obesity +1 more
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnoea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal glucose tolerance

Patients with normal fasting glucose. Blood glucose less than 5.6mmol/L

Questionnaire

Intervention Type OTHER

Impaired fasting glycaemia

Patients with blood glucose between 5.6mmol/L - 7mmol/L

Questionnaire

Intervention Type OTHER

Type 2 diabetes

Patients with blood glucose higher than 7mmol/L and negative IA2 and GAD antibodies.

Questionnaire

Intervention Type OTHER

Type 1 diabetes

Patients on insulin and with positive IA2 and/or GAD antibodies.

Questionnaire

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants aged between 18-64 years old. Both Gender male and female.

Exclusion Criteria

Paediatrics below the age of 18. Any participant who is unable to take part
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Imperial College London Diabetes Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Nader Lessan, MD

Consultant Endocrinologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imperial College London Diabetes Centre

Abu Dhabi, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IREC020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of AD128 Versus Placebo in Obstructive Sleep Apnea
NCT04449133 COMPLETED PHASE2
Relationship Between Obstructive Sleep Apnea and Coronary Atherosclerosis
NCT01306526 COMPLETED
Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community
NCT03280914 COMPLETED
A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
NCT04262986 UNKNOWN
Effect of AD128 to Treat Obstructive Sleep Apnea
NCT04394143 COMPLETED PHASE2/PHASE3
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia
NCT03695315 ACTIVE_NOT_RECRUITING
Screening for Obstructive Sleep Apnea in Medical Patients
NCT05980936 WITHDRAWN
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
NCT00194259 UNKNOWN
Obstructive Sleep Apnoea and Difficult Asthma (OSADA)
NCT07160868 RECRUITING NA
Obstructive Sleep Apnea and Glucose Metabolism
NCT03408613 SUSPENDED NA
A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep
NCT05458193 COMPLETED PHASE1
Multidisciplinary Network OSA Code (Obstructive Apnea Syndrome): Digital Operative Model in Public Health for an Early Diagnosis and Therapy Monitoring
NCT06677580 RECRUITING
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea
NCT03232658 UNKNOWN
Lifestyle Modification Program to Treat Obstructive Sleep Apnea Patients
NCT01384760 COMPLETED NA
Ultrasound Versus Clinical Tests as Predictors of Difficult Endotracheal Intubation in Patients With Obstructive Sleep Apnoea Undergoing Elective Surgery Under General Anaesthesia
NCT05402683 UNKNOWN
Cardiopulmonary Exercise Test in Patient With Obstructive Sleep Apnea
NCT03300700 UNKNOWN
Asthma and Obstructive Sleep Apnea (OSA)
NCT01026298 COMPLETED NA
Lifestyle Intervention for OSA in Adults
NCT03851653 COMPLETED NA
CPAP and Glucose Metabolism in Non-Diabetic OSA Subjects
NCT05335083 NOT_YET_RECRUITING NA
Impact of CPAP Treatment on Arterial Stiffness in Patients With T2DM and Newly Diagnosed Obstructive Sleep Apnoea
NCT02482584 UNKNOWN NA
Correlation Between Nocturnal Oxygen Desaturation and Glycemic Control in Diabetic Patients With Obstructive Sleep Apnea
NCT04711083 COMPLETED
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease
NCT03373643 UNKNOWN NA
CPAP in Diabetes Type 2 Patients With Sleep Apnea
NCT01801150 COMPLETED PHASE4
Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome
NCT05245240 UNKNOWN NA
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
NCT01447251 COMPLETED NA